<h3>&nbsp;</h3>

<h3>for general enquiries</h3>

<p>Address</p>

<h5>Shire International GmbH<br />
Zählerweg 10<br />
6301 Zug - Switzerland</h5>

<p>Telephone</p>

<h5>+41 41 288 4000</h5>

<p>Fax</p>

<h5>+41 41 288 4001</h5>

<h3>&nbsp;</h3>

<h3>for medical information enquiries</h3>

<p>Europe, Middle East, and Africa</p>

<h5>medinfoEMEA@shire.com</h5>

<p>US</p>

<h5>medinfoUS@shire.com</h5>

<p>Canada</p>

<h5>medinfoCA@shire.com</h5>

<p>Japan and Asia Paciﬁc</p>

<h5>medinfoAPAC@shire.com</h5>

<p>Latin America</p>

<h5>medinfoLATAM@shire.com</h5>

<p>Rest of the world</p>

<h5>medinfoEMEA@shire.com</h5>

<h3>&nbsp;</h3>

<h3>reporting suspected side effects (also known as adverse drug reactions) related to a shire product:</h3>

<p>Email</p>

<h5>drugsafety@shire.com</h5>

<p><em>Shire is now part of Takeda.</em></p>

<h3>&nbsp;</h3>

<h3>for investor or media enquiries</h3>

<p>Email</p>

<h5>media_relations@takeda.com</h5>
